These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24945464)

  • 1. Pazopanib combined with radiation: in vivo model of interaction.
    Meredith RF; Raisch KP; Bonner JA; Buchsbaum DJ; Grizzle WE; Li Y; Spencer SA
    Cancer Biother Radiopharm; 2014 Aug; 29(6):247-50. PubMed ID: 24945464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats.
    Ning S; Tian J; Marshall DJ; Knox SJ
    Cancer Res; 2010 Oct; 70(19):7591-9. PubMed ID: 20841470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
    Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC
    BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
    Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
    Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
    Huang SM; Harari PM
    Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.
    Papadopoulou MV; Bloomer WD; Taylor AP; Hernandez M; Blumenthal RD; Hollingshead MG
    Radiat Res; 2007 Jul; 168(1):65-71. PubMed ID: 17722994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
    Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH
    Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).
    Huang SM; Li J; Armstrong EA; Harari PM
    Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pazopanib on tumor microenvironment and liposome delivery.
    Tailor TD; Hanna G; Yarmolenko PS; Dreher MR; Betof AS; Nixon AB; Spasojevic I; Dewhirst MW
    Mol Cancer Ther; 2010 Jun; 9(6):1798-808. PubMed ID: 20515941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.
    Kozin SV; Boucher Y; Hicklin DJ; Bohlen P; Jain RK; Suit HD
    Cancer Res; 2001 Jan; 61(1):39-44. PubMed ID: 11196192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts.
    Rofstad EK; Henriksen K; Galappathi K; Mathiesen B
    Cancer Res; 2003 Jul; 63(14):4055-61. PubMed ID: 12874006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
    Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab-bevacizumab-irradiation combination on head and neck cancer xenografts.
    Bozec A; Etienne-Grimaldi MC; Fischel JL; Sudaka A; Toussan N; Formento P; Milano G
    Oral Oncol; 2011 May; 47(5):340-4. PubMed ID: 21421338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Sep; 118(9):2739-2743. PubMed ID: 28176365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model.
    Ruda JM; Beus KS; Hollenbeak CS; Wilson RP; Stack BC
    Invest New Drugs; 2006 Sep; 24(5):377-81. PubMed ID: 16505952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
    Skvortsova I; Skvortsov S; Raju U; Stasyk T; Riesterer O; Schottdorf EM; Popper BA; Schiestl B; Eichberger P; Debbage P; Neher A; Bonn GK; Huber LA; Milas L; Lukas P
    Radiother Oncol; 2010 Jul; 96(1):108-15. PubMed ID: 20451273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pazopanib: Clinical development of a potent anti-angiogenic drug.
    Schutz FA; Choueiri TK; Sternberg CN
    Crit Rev Oncol Hematol; 2011 Mar; 77(3):163-71. PubMed ID: 20456972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.